| Skip navigation | ||
![]() |
![]() | ![]() |
|
|
||
Endocervical gram stain is a method of identifying bacteria on tissue from the cervix using a special series of stains.
The health care provider will obtain a tissue sample from the lining of the cervical canal (the opening to the uterus).
You lie on your back with your feet in stirrups. As in a regular pelvic examination, a speculum (an instrument used to stretch open the vagina in order to better examine some of the pelvic organs) will be inserted and opened slightly.
The cervix is cleaned so there is no mucus. A dry, sterile swab is then inserted and rotated in the cervical canal. It may be left in place for several seconds to absorb as many of the organisms as possible.
The swab is then removed and sent to a laboratory, where it will be smeared on a slide. A series of stains called a gram stain is applied to the specimen.
A laboratory technician examines the stained smear under the microscope for the presence of bacteria. The color, size, and shape of the cells help identify the type of bacteria.
Do not douche for 24 hours before the procedure.
You may feel minor discomfort during specimen collection. This procedure feels very much like a routine Pap smear.
The test is used to detect and identify abnormal bacteria in the area of the cervix. If you develop signs of an infection or suspect that you have a sexually transmitted disease (such as gonorrhea), this test can help confirm the diagnosis, and identify the organism that is causing the infection.
There are no abnormal bacteria present. Note that the normal cervix has "friendly" bacteria that the gram stain will pick up.
There is virtually no risk.
If you have gonorrhea or another sexually transmitted infection, it is very important that all of your sexual partners also receive treatment, even if they have no symptoms.
Gram stain of cervix
Workowski KA, Berman SM. Diseases characterized by urethritis and cervicitis. Sexually transmitted diseases treatment guidelines 2006. Centers for Disease Control and Prevention. MMWR. 2006 Aug 4;55(RR-11):35-49.
Centers for Disease Control and Prevention (CDC). Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR. 2007 Apr 13;56(14):332-6.
Updated by: Linda J. Vorvick, MD, Medical Director, MEDEX Northwest Division of Physician Assistant Studies, University of Washington, School of Medicine. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
|
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch). |

| Home | Health Topics | Drugs & Supplements | Encyclopedia | Dictionary | News | Directories | Other Resources | |
| Disclaimers | Copyright | Privacy | Accessibility | Quality Guidelines U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health | Department of Health & Human Services |
Page last updated: 29 October 2009 |